We have also previously reported that lncRNA SNHG17 acts to interact with PRC2, thereby promoting cell cycle progression and proliferation of GC cells by epigenetic silencing of the major cyclin-dependent kinase inhibitors (CKIs) including p15 and p57 [15]. Here, CDKN2B is linked to gastric cancer.